Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Rangering i aksjer
#2197
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Aksjekurs
$3.40
Markedsverdi
$9.07B
Endring (1 dag)
-1.61%
Endring (1 år)
-16.08%
Land
CN
Handel Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Kategori
Healthcare
P/S-forhold for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
P/S-forhold per 2026 TTM: 0
Ifølge Shanghai Fosun Pharmaceutical (Group) Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. fra 2001 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2025 | 1.69 | 4.80% |
| 2024 | 1.61 | 0.10% |
| 2023 | 1.61 | -22.99% |
| 2022 | 2.09 | -34.98% |
| 2021 | 3.22 | -29.58% |
| 2020 | 4.57 | 91.44% |
| 2019 | 2.38 | 9.32% |
| 2018 | 2.18 | -63.06% |
| 2017 | 5.91 | 61.09% |
| 2016 | 3.67 | -14.40% |
| 2015 | 4.28 | 6.40% |
| 2014 | 4.03 | -7.88% |
| 2013 | 4.37 | 57.04% |
| 2012 | 2.78 | 10.47% |
| 2011 | 2.52 | -54.62% |
| 2010 | 5.55 | -11.49% |
| 2009 | 6.27 | 80.89% |
| 2008 | 3.47 | -32.97% |
| 2007 | 5.17 | 295.14% |
| 2006 | 1.31 | -8.44% |
| 2005 | 1.43 | -21.64% |
| 2004 | 1.82 | -11.63% |
| 2003 | 2.06 | -48.23% |
| 2002 | 3.99 | -43.85% |
| 2001 | 7.10 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | - |
IN
|
